IRIS
GALEAZZI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 40.289
EU - Europa 32.303
AS - Asia 15.410
SA - Sud America 2.753
AF - Africa 707
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 30
AN - Antartide 1
Totale 91.539
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 39.845
GB - Regno Unito 9.306
CN - Cina 5.786
RU - Federazione Russa 4.982
SG - Singapore 4.741
IT - Italia 4.106
IE - Irlanda 3.639
UA - Ucraina 2.769
BR - Brasile 2.311
SE - Svezia 2.072
FR - Francia 1.860
DE - Germania 1.833
VN - Vietnam 1.335
HK - Hong Kong 1.162
FI - Finlandia 898
KR - Corea 708
IN - India 349
ZA - Sudafrica 323
BD - Bangladesh 318
CA - Canada 227
TR - Turchia 173
AR - Argentina 160
ES - Italia 158
IQ - Iraq 151
NL - Olanda 141
MX - Messico 120
PL - Polonia 108
NG - Nigeria 106
JP - Giappone 100
BE - Belgio 97
ID - Indonesia 74
CI - Costa d'Avorio 69
PK - Pakistan 67
EC - Ecuador 65
CZ - Repubblica Ceca 57
VE - Venezuela 52
MA - Marocco 51
SA - Arabia Saudita 48
UZ - Uzbekistan 44
AT - Austria 43
CO - Colombia 42
AU - Australia 36
TN - Tunisia 36
CL - Cile 35
LT - Lituania 33
KE - Kenya 30
NP - Nepal 30
AE - Emirati Arabi Uniti 29
JO - Giordania 29
PH - Filippine 29
EG - Egitto 27
KZ - Kazakistan 26
MY - Malesia 26
PY - Paraguay 26
EU - Europa 25
IR - Iran 25
PE - Perù 25
GR - Grecia 24
CH - Svizzera 22
IL - Israele 21
DZ - Algeria 20
UY - Uruguay 20
BG - Bulgaria 19
RO - Romania 19
JM - Giamaica 18
AZ - Azerbaigian 16
DO - Repubblica Dominicana 16
DK - Danimarca 15
BO - Bolivia 14
AL - Albania 13
CR - Costa Rica 13
PT - Portogallo 13
KG - Kirghizistan 12
LB - Libano 12
KW - Kuwait 11
ET - Etiopia 10
HU - Ungheria 10
OM - Oman 10
RS - Serbia 10
SK - Slovacchia (Repubblica Slovacca) 9
SY - Repubblica araba siriana 9
TH - Thailandia 9
BH - Bahrain 8
TT - Trinidad e Tobago 8
HN - Honduras 7
HR - Croazia 7
PA - Panama 7
AM - Armenia 6
GT - Guatemala 6
LU - Lussemburgo 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
SV - El Salvador 6
TW - Taiwan 6
AO - Angola 5
CY - Cipro 5
EE - Estonia 5
KH - Cambogia 5
SN - Senegal 5
Totale 91.438
Salva come PNG Salva come JPEG
Città #
Southend 8.589
Dallas 4.350
Fairfield 3.998
Dublin 3.600
Ashburn 2.859
Singapore 2.717
Menlo Park 2.428
Chandler 2.255
Jacksonville 2.238
Woodbridge 1.904
Houston 1.879
Wilmington 1.547
Seattle 1.497
Santa Clara 1.387
Beijing 1.351
Cambridge 1.342
Moscow 1.302
Milan 1.184
Ann Arbor 1.163
Hong Kong 1.111
San Jose 1.110
Nanjing 763
Princeton 735
Hefei 725
Seoul 682
The Dalles 680
Siena 529
New York 487
Council Bluffs 464
Los Angeles 458
Rome 423
Ho Chi Minh City 418
Lauterbourg 388
Helsinki 381
Boardman 335
Hanoi 326
San Mateo 316
Johannesburg 291
Munich 281
San Diego 252
Nanchang 251
Buffalo 245
São Paulo 214
Dearborn 181
Columbus 180
Shenyang 178
Düsseldorf 162
Shanghai 144
Tianjin 133
Changsha 130
Hebei 127
Figino 121
Orem 114
Venezia 107
Jiaxing 106
Abuja 102
London 96
Málaga 96
Brussels 90
Dong Ket 90
Kunming 90
Turku 89
Lancaster 88
Toronto 88
Jinan 83
San Francisco 83
Tokyo 83
Frankfurt am Main 81
Guangzhou 79
Rio de Janeiro 78
Warsaw 75
Chennai 71
Bengaluru 70
Brooklyn 70
Abidjan 69
Redondo Beach 68
Belo Horizonte 66
Norwalk 66
Zhengzhou 65
Florence 64
Chicago 63
Da Nang 63
Turin 62
Washington 62
Izmir 60
Montreal 59
Saint Petersburg 53
Baghdad 52
Denver 52
Haiphong 50
Hangzhou 50
Mestre 50
Ningbo 50
Stockholm 47
Bologna 45
Boston 45
Changchun 44
Falls Church 44
Brasília 43
Phoenix 43
Totale 64.175
Salva come PNG Salva come JPEG
Nome #
UNIREUMA -REUMATOLOGIA PER STUDENTI E MEDICI DI MEDICINA GENERALE I EDIZIONE 674
Livello sierico della COMP (Cartilage Oligomeric Matrix Protein): Uso potenziale come marker di progressione del danno articolare nei pazienti con "Early Rheumatoid Arthritis" 483
Comparison of combination therapies in the treatment of rheumatoid arthritis :leflunomide-anti-TNF-alfa versus methotrexate-anti-TNF-alfa 477
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 422
null 412
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 408
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 397
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 397
Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung 389
A "new" technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography 369
Expression of RXFP1 in skin of scleroderma patients and control subjects 366
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 361
AB0969 Accuracy of blind intra-articular injections in patients with osteoarthritis of the knee. An ultrasonography controlled study 358
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 353
Alkaptonuria is a novel human secondary amyloidogenic disease 351
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 350
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 344
AB0535 Effects of tocilizumab on bone density and metabolism in patients with active rheumatoid arthritis 336
A novel ex vivo organotypic culture model of alkaptonuria-ochronosis 324
Bone mineral density in patients with systemic sclerosis. 322
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry 320
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 320
A case of amyloid myopathy in a patient with familial Mediterranean fever 319
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 318
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 316
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 316
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 316
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 315
Change perspective to increase diagnostic accuracy of ultrasonography in calcium pyrophosphate dehydrate deposition disease! A new approach: The axial scan of the meniscus 312
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 311
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 311
Deltoideal acromial enthesopathy in ankylosing spondylitis and in spondylarthropathies: comment on the article by Lambert et al. 311
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 311
Circulating levels of adiponectin, resistin, and visfatin after mud-bath therapy in patients with bilateral knee osteoarthritis 305
Colchicine myopathy and neuromyopathy: two cases with different characteristics 305
AB1308 Prevalence of baker’s CYST in patients with chronic gonalgia and relationship with major non inflammatory diseases 303
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes 302
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 301
Obesity reduces the response rate to anti TNFα in rheumatoidarthritis. an approach to a personalized medicine 300
Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature 300
Could oxidative stress regulate the expression of microRNA-146a and microRNA-34a in human osteoarthritic chondrocyte cultures? 300
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis 298
High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus 298
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 297
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 296
A whitish-creamysynovial fluid. 296
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 296
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 296
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 295
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 294
Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. 293
Validation of an Italian version of the functional index for hand osteoarthritis (FIHOA) 292
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 289
Ultrasonography and magnetic resonance imaging of heel fat pad inflammatory-oedematous lesions in rheumatoid arthritis 286
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 285
FRI0501 Ultrasound versus synovial fluid analysis for the diagnosis of calcium pyrophosphate dihydrate deposition disease: preliminary results 285
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 281
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 281
The Immunogenetics of the Antiphospholipid Syndrome, Anticardiolipin Antibodies, and Lupus Anticoagulant 280
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 278
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus 276
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 275
One-year follow-up of mud-bath therapy in patients with bilateral knee osteoarthritis: a randomized, single-blind controlled trial 275
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 273
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 272
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 268
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 268
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 267
Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk 265
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 263
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 262
Granulomatosis with polyangiitis and intravenous immunoglobulins: A case series and review of the literature 261
Hydrostatic pressure regulates MicroRNA expression levels in osteoarthritic chondrocyte cultures via the Wnt/β-catenin pathway 261
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 260
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 259
A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus 259
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 259
SAT0312 Ultrasound Reliability in the Diagnosis of Calcium Pyrophosphate Deposition Disease: Agreement Between Observers and Main Causes of Discordance 256
Can hybrid hyaluronic acid represent a valid approach to treat rizoarthrosis? A retrospective comparative study 256
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 255
Anomalie cromosomiche, valutate come frequenza di micronuclei spontanei, in soggetti con fenomeno di Raynaud sospetto presclerodermico [Chromosome aberrations, valued as frequency of spontaneous micronuclei, in subjects with suspected presclerodermic Raynaud's phenomenon] 255
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 253
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 253
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 252
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 251
FRI0533 Ultrasonographic Features of Joints and Entheses in Healty Children 251
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? 250
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 249
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 248
SAT0542 The Prevalence of Calcium Pyrophosphate Deposits at Ultrasound Examination: Retrospective Analysis in A Cohort of Patients 247
Chromosome aberrations in Raynaud's phenomenon 247
Autoinflammatory disorders and patients with isolated serosal involvement. 246
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 246
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 245
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 245
Weekly oral alendronate in mevalonate kinase deficiency 244
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 244
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies 243
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 241
SAT0315 Calcium Pyrophosphate Dihydrate Deposition Disease: A Proposal of New Ultrasonographic Criteria for CPP Identification in the Joints 241
Totale 30.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 263.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 263.860
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.301 532 768 428 492 430 157 258 244 441 737 589 1.225
2022/20238.015 533 577 1.075 1.184 870 1.650 108 628 832 164 255 139
2023/20245.268 231 130 438 299 187 1.548 1.750 142 24 61 71 387
2024/202510.488 229 608 856 615 1.281 529 250 616 844 403 1.257 3.000
2025/202626.188 1.945 3.988 3.086 2.862 4.777 1.126 2.619 751 747 1.183 600 2.504
2026/2027263 263 0 0 0 0 0 0 0 0 0 0 0
Totale 92.104